Table 1.
The projected timeline of the COVID-19 vaccines safety tracking (CoVaST) study.
| Phase | Stage | Population | Schedule |
|---|---|---|---|
| Phase A | Stage A.1. | HCWs | May–August 2021 |
| Stage A.2. | SAs | June–December 2021 | |
| Stage A.3. | TAs | June–December 2021 | |
| Stage A.4. | MIs | June–December 2021 | |
| Phase B | Stage B.1. | HCWs | October 2021–February 2021 |
| Stage B.2. | SAs | November 2021–April 2022 | |
| Stage B.3. | TAs | November 2021–April 2022 | |
| Stage B.4. | MIs | November 2021–April 2022 | |
| Stage C | Stage C.1. | HCWs, SAs, TAs, MIs | January–December 2022 |
| Stage C.2. | HCWs, SAs, TAs, MIs | January–December 2023 | |
| Stage C.3. | HCWs, SAs, TAs, MIs | January–December 2024 | |
| Stage C.4. | HCWs, SAs, TAs, MIs | January–December 2025 | |
| Stage C.5. | HCWs, SAs, TAs, MIs | January–December 2026 |
HCWs = Healthcare Workers; SAs = Senior Adults; TAs = Teachers and Academics; MIs = Minors.